September 19, 2007 - With better quality sound, reproducibility potential for computer analysis, file-sharing and ...
September 18, 2007 - The DuraHeart Left Ventricular Assist System (LVAS) reported a survival rate of 77 percent for all ...
September 18, 2007 - St. Jude Medical Inc. announced FDA approval of its first radiofrequency (RF) wireless devices to treat patients with heart failure and with potentially lethal heart arrhythmias.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
September 18, 2007 - Vasogen Inc. announced plans for a confirmatory study of its Celacade technology for the treatment ...
September 18, 2007 - Baseline data from the largest study of U.S.-based heart failure (HF) patients in the outpatient ...
September 18, 2007 – CardioDynamics, an impedance cardiography (ICG) technology developer, announced plans to accelerate ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
September 18, 2007 - Angiotech Pharmaceuticals Inc. announced that it reached a favorable agreement with Johnson & ...
September 18, 2007 - Forty-one U.S. hospitals have been named 2007 Leapfrog Top Hospitals, based on results from the ...
September 17, 2007 – GHX announced the winners of the fourth annual Best In Class Awards, recognizing medical/surgical ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
September 14, 2007 - In the largest study of its kind to date, comparing the CYPHER Sirolimus-eluting Coronary Stent and ...
September 14, 2007 - For many years, American Heart Association research has supported education and training programs ...
September 14, 2007 - Boston Scientific Corp. released data reflecting experience from the first 15,000 patients ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
September 13, 2007 - Therapeutic hypothermia is still considered experimental by many, but doctors for Buffalo Bills' ...
September 13, 2007 - Medical device maker Somanetics Corp. announced that The Society of Thoracic Surgeons (STS) has ...
September 13, 2007 - Millennium Research Group (MRG) conducted a detailed analysis of the stem cell therapy market in its "U.S. Markets for Stem Cell Therapies 2007" report, which shows while the market for stem cell therapies is in its infancy, it will grow rapidly as products are approved in the U.S.